Walleye Capital LLC Increases Stock Holdings in Science 37 Holdings, Inc. (NASDAQ:SNCE)

Walleye Capital LLC raised its stake in Science 37 Holdings, Inc. (NASDAQ:SNCEGet Rating) by 2,261.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 309,956 shares of the company’s stock after purchasing an additional 296,828 shares during the period. Walleye Capital LLC’s holdings in Science 37 were worth $1,658,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of SNCE. Redmile Group LLC acquired a new stake in Science 37 in the 4th quarter valued at about $247,009,000. Casdin Capital LLC acquired a new stake in Science 37 in the 4th quarter valued at about $22,446,000. Perceptive Advisors LLC acquired a new stake in Science 37 in the 4th quarter valued at about $18,705,000. Citadel Advisors LLC acquired a new stake in Science 37 in the 4th quarter valued at about $17,701,000. Finally, Samsara BioCapital LLC acquired a new stake in Science 37 in the 4th quarter valued at about $11,223,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on SNCE shares. Craig Hallum reduced their price target on Science 37 to $7.00 in a research report on Monday, August 15th. Robert W. Baird cut their target price on Science 37 from $9.00 to $6.00 in a research report on Friday, August 12th. Finally, Cowen cut their target price on Science 37 to $7.00 in a research report on Monday, August 15th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $10.80.

Science 37 Stock Down 3.1 %

SNCE opened at $1.85 on Friday. The firm has a market cap of $215.25 million, a price-to-earnings ratio of -0.52 and a beta of 1.92. Science 37 Holdings, Inc. has a 52 week low of $1.43 and a 52 week high of $15.10. The business’s 50 day moving average is $1.87 and its two-hundred day moving average is $3.26.

Science 37 (NASDAQ:SNCEGet Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.04. The company had revenue of $19.28 million for the quarter, compared to analyst estimates of $19.20 million. Science 37 had a negative return on equity of 87.95% and a negative net margin of 56.12%. Equities analysts expect that Science 37 Holdings, Inc. will post -0.65 EPS for the current fiscal year.

About Science 37

(Get Rating)

Science 37 Holdings, Inc provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data.

Further Reading

Want to see what other hedge funds are holding SNCE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Science 37 Holdings, Inc. (NASDAQ:SNCEGet Rating).

Institutional Ownership by Quarter for Science 37 (NASDAQ:SNCE)

Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.